TY - JOUR
T1 - Outcome Following Hemorrhage From Cranial Dural Arteriovenous Fistulae
T2 - Analysis of the Multicenter International CONDOR Registry
AU - Koch, Matthew J.
AU - Stapleton, Christopher J.
AU - Guniganti, Ridhima
AU - Lanzino, Giuseppe
AU - Sheehan, Jason
AU - Alaraj, Ali
AU - Bulters, Diederik
AU - Kim, Louis
AU - Fox, W. Christopher
AU - Gross, Bradley A.
AU - Hayakawa, Minako
AU - Van Dijk, J. Marc C.
AU - Starke, Robert M.
AU - Satomi, Junichiro
AU - Polifka, Adam J.
AU - Zipfel, Gregory J.
AU - Amin-Hanjani, Sepideh
N1 - Publisher Copyright:
© 2021 American Heart Association, Inc.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - Background and Purpose: Dural arteriovenous fistulae can present with hemorrhage, but there remains a paucity of data regarding subsequent outcomes. We sought to use the CONDOR (Consortium for Dural Arteriovenous Fistula Outcomes Research), a multi-institutional registry, to characterize the morbidity and mortality of dural arteriovenous fistula-related hemorrhage. Methods: A retrospective review of patients in CONDOR who presented with dural arteriovenous fistula-related hemorrhage was performed. Patient characteristics, clinical follow-up, and radiographic details were analyzed for associations with poor outcome (defined as modified Rankin Scale score ≥3). Results: The CONDOR dataset yielded 262 patients with incident hemorrhage, with median follow-up of 1.4 years. Poor outcome was observed in 17.0% (95% CI, 12.3%-21.7%) at follow-up, including a 3.6% (95% CI, 1.3%-6.0%) mortality. Age and anticoagulant use were associated with poor outcome on multivariable analysis (odds ratio, 1.04, odds ratio, 5.1 respectively). Subtype of hemorrhage and venous shunting pattern of the lesion did not affect outcome significantly. Conclusions: Within the CONDOR registry, dural arteriovenous fistula-related hemorrhage was associated with a relatively lower morbidity and mortality than published outcomes from other arterialized cerebrovascular lesions but still at clinically consequential rates.
AB - Background and Purpose: Dural arteriovenous fistulae can present with hemorrhage, but there remains a paucity of data regarding subsequent outcomes. We sought to use the CONDOR (Consortium for Dural Arteriovenous Fistula Outcomes Research), a multi-institutional registry, to characterize the morbidity and mortality of dural arteriovenous fistula-related hemorrhage. Methods: A retrospective review of patients in CONDOR who presented with dural arteriovenous fistula-related hemorrhage was performed. Patient characteristics, clinical follow-up, and radiographic details were analyzed for associations with poor outcome (defined as modified Rankin Scale score ≥3). Results: The CONDOR dataset yielded 262 patients with incident hemorrhage, with median follow-up of 1.4 years. Poor outcome was observed in 17.0% (95% CI, 12.3%-21.7%) at follow-up, including a 3.6% (95% CI, 1.3%-6.0%) mortality. Age and anticoagulant use were associated with poor outcome on multivariable analysis (odds ratio, 1.04, odds ratio, 5.1 respectively). Subtype of hemorrhage and venous shunting pattern of the lesion did not affect outcome significantly. Conclusions: Within the CONDOR registry, dural arteriovenous fistula-related hemorrhage was associated with a relatively lower morbidity and mortality than published outcomes from other arterialized cerebrovascular lesions but still at clinically consequential rates.
KW - anticoagulant
KW - arteriovenous fistula
KW - fistula
KW - hemorrhage
KW - morbidity
KW - mortality
KW - registry
UR - http://www.scopus.com/inward/record.url?scp=85116563167&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.121.034707
DO - 10.1161/STROKEAHA.121.034707
M3 - Article
C2 - 34433307
AN - SCOPUS:85116563167
SN - 0039-2499
VL - 52
SP - E610-E613
JO - Stroke
JF - Stroke
IS - 10
ER -